The Latest Cardiac and Vascular News
SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular applications, today announced enrollment of the first patients in FLAGSHIP, the Company’s prospective, single‑arm, open‑label first‑in‑human study evaluating its investigational False Lumen Embolization (FLE) System for the treatment of aortic dissection. Aortic dissection is a life‑threatening condition in which a tear in the aortic wall creates a secondary channel known as
AUDUBON, Pa., March 31, 2026 /PRNewswire/ — AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral vascular disorders, today announced the appointment of Dr. John N. Evans, DPM, FACFAS, DABFAS, to a lead role as Medical…
TAMPA, Fla., March 31, 2026 /PRNewswire/ — Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world’s largest randomised controlled trial of a Sirolimus-coated balloon for Peripheral…
Microbot Medical® Strengthens LIBERTY®’s Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
MENLO PARK, Calif., March 19, 2026 /PRNewswire/ — Endovascular Engineering, Inc. (“E2”) today announced that two abstracts related to the ENGULF study and the Hēlo® Platform have been accepted as late-breaking podium presentations at the Society of Interventional Radiology (SIR) Annual…
MINNEAPOLIS, March 5, 2026 /PRNewswire/ — VentureMed Group, Inc., an innovative medical device company specializing in vessel preparation and access management for AV fistulas and grafts and peripheral vascular disease, today announced it is now doing business as Flex Vascular. The DBA…
DALLAS, March 2, 2026 /PRNewswire/ — Koya Medical (“Koya”) has announced a multi-society endorsed position statement published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders supporting the clinical utility of non-pneumatic compression (NPCD) for the treatment of…
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
A Breakthrough in Dialysis Access ST. LOUIS, Jan. 13, 2026 /PRNewswire/ — Amplifi Vascular, Inc., has been granted Breakthrough Device Designation and Category B assignment from the Centers for Medicare & Medicaid Services (CMS) for the Amplifi Vein Dilation System. This significant…
NEW YORK, Jan. 9, 2026 /PRNewswire/ — Major Medical Devices, Inc. (http://www.majormedicaldevices.com) (MMD), an emerging innovator in vascular intervention technologies with a highly differentiated, potentially quick to market device in a $3 billion market, announces strategic funding…
